Table 2.
The comparison of the COH results.
| Group 1∗
(n = 46) |
Group 2∗∗
(n = 85) |
p value | |
|---|---|---|---|
| Duration of the treatment (days) | 12 (7–30) | 11 (7–16) | 0.003 |
| Dose of FSH (IU) | 4200 (750–12600) | 3375 (0–8550) | 0.016 |
| Total dose of HMG (IU) | 562,5 (0–4500) | 450 (0–4200) | 0.397 |
| Starting time of antagonist (day) | 7 (0–11) | 9 (5–13) | 0.001 |
| E2 level on hCG day (pg/mL) | 1129 (224–10840) | 1206 (219–9570) | 0.186 |
| Number of antral follicles at USG on hCG day | 3 (0–7) | 3 (1–12) | 0.640 |
The values are given as the medians (minimum–maximum).
∗A microdose GnRH agonist flare-up combined with a flexible multidose GnRH antagonist protocol.
∗∗A flexible multidose GnRH antagonist protocol.